ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Scope & Guideline

Advancing cardiovascular knowledge through groundbreaking research.

Introduction

Welcome to the ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1079-5642
PublisherLIPPINCOTT WILLIAMS & WILKINS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1990 to 2024
AbbreviationARTERIOSCL THROM VAS / Arterioscler. Thromb. Vasc. Biol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103

Aims and Scopes

The journal "Arteriosclerosis, Thrombosis, and Vascular Biology" (ATVB) is dedicated to publishing high-quality research that advances the understanding of vascular biology, particularly in relation to cardiovascular diseases, thrombosis, and atherosclerosis. The journal emphasizes both basic and clinical research, fostering an interdisciplinary approach that incorporates molecular biology, genetics, and epidemiology.
  1. Vascular Biology and Pathophysiology:
    Research focused on the cellular and molecular mechanisms underlying vascular health and disease, including endothelial function, smooth muscle cell dynamics, and the role of vascular inflammation in atherogenesis.
  2. Thrombosis and Hemostasis:
    Investigations into the mechanisms of blood clot formation and resolution, including studies on platelets, coagulation factors, and the impact of various pathological conditions on thrombotic processes.
  3. Atherosclerosis Mechanisms:
    Studies elucidating the pathophysiology of atherosclerosis, including lipid metabolism, inflammatory processes, and the role of immune cells in plaque formation and stability.
  4. Genetic and Environmental Risk Factors:
    Exploration of genetic determinants and environmental influences on cardiovascular disease risk, with a focus on identifying novel biomarkers and therapeutic targets.
  5. Innovative Therapeutic Strategies:
    Research on new therapeutic approaches for cardiovascular diseases, including drug development, gene therapy, and the use of advanced biomaterials for vascular repair.
  6. Translational Research:
    Bridging basic science with clinical applications, aiming to translate findings from laboratory research into effective treatments and interventions for cardiovascular diseases.
The journal has shown a dynamic evolution in its focus areas, with emerging themes reflecting the latest advancements in vascular biology, technology, and clinical practice. These trends indicate a shift towards more integrated and innovative research methodologies.
  1. Precision Medicine Approaches:
    An increasing number of studies focus on personalized medicine, utilizing genetic and molecular profiling to tailor interventions for cardiovascular diseases, reflecting a broader trend in healthcare.
  2. Role of the Microbiome:
    Research exploring the influence of gut microbiota on cardiovascular health is gaining traction, with studies linking microbial metabolites to vascular inflammation and atherosclerosis.
  3. Immunometabolism in Cardiovascular Disease:
    The intersection of immune responses and metabolic processes in vascular disease is emerging as a critical area of research, highlighting the role of inflammation in atherosclerosis and thrombosis.
  4. Innovative Imaging and Biomarker Technologies:
    Advancements in imaging techniques and biomarker discovery are increasingly featured, enabling more precise monitoring of vascular health and disease progression.
  5. Novel Therapeutic Modalities:
    There is a rising interest in novel therapeutic strategies, including the use of nanoparticles, CRISPR technology, and RNA-based therapies, aimed at addressing vascular disease at a molecular level.
  6. Cellular Plasticity and Regenerative Medicine:
    Research on the plasticity of vascular cells and their potential for regeneration and repair is becoming more prominent, particularly in the context of stem cell therapies and tissue engineering.

Declining or Waning

While the journal continues to thrive in many areas, some themes have seen a decline in focus over recent years. These waning scopes may reflect shifts in research priorities or advancements in understanding that have led to saturation in particular topics.
  1. Traditional Risk Factor Studies:
    Research focusing solely on conventional cardiovascular risk factors (e.g., hypertension, cholesterol levels) has decreased as the field moves towards more complex, multifactorial models of disease.
  2. Basic Animal Models:
    There is a noticeable reduction in studies utilizing traditional animal models without incorporating modern techniques such as genetic manipulation or advanced imaging, as researchers seek more relevant and translationally applicable models.
  3. Single-Factor Interventions:
    Research that examines the effects of single interventions on vascular health, without considering the multifaceted interactions present in human health, is becoming less prevalent as the complexity of cardiovascular disease is better appreciated.
  4. Epidemiological Studies with Limited Scope:
    Epidemiological studies that focus narrowly on specific populations without integrating broader systemic factors are declining, as there is a push for more comprehensive approaches to understanding cardiovascular health across diverse populations.

Similar Journals

CIRCULATION RESEARCH

Leading the way in cardiovascular research since 1953.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0009-7330Frequency: 24 issues/year

CIRCULATION RESEARCH is a premier journal dedicated to advancing the field of cardiovascular science, focusing on innovative research in cardiology and physiology. Published by Lippincott Williams & Wilkins, this esteemed journal has been a cornerstone of cardiovascular research since its inception in 1953, maintaining rigorous standards of scholarly excellence. With an impressive impact factor and ranking in the top quartiles for both Cardiology and Cardiovascular Medicine (Q1) and Physiology (Q1), it holds a significant position in the Scopus database. This journal features cutting-edge studies aimed at understanding the mechanisms of cardiovascular health and disease, promoting the translation of research into clinical practice. Weekly issues provide practitioners and researchers alike with vital insights to keep abreast of the latest developments. Although it does not offer open access, CIRCULATION RESEARCH remains vital for professionals striving to enhance their knowledge and impact in the ever-evolving landscape of cardiovascular medicine.

Current Atherosclerosis Reports

Elevating the standard of cardiovascular scholarship.
Publisher: CURRENT MEDICINE GROUPISSN: 1523-3804Frequency: 12 issues/year

Current Atherosclerosis Reports, published by CURRENT MEDICINE GROUP, is a leading scientific journal in the field of Cardiology and Cardiovascular Medicine, boasting an impressive Q1 ranking in its category as of 2023. This esteemed journal, with an ISSN of 1523-3804 and an E-ISSN of 1534-6242, has been a cornerstone of cardiovascular research since its inception in 1999, continuing to publish cutting-edge studies through 2024. With unparalleled insights into the mechanisms, prevention, and treatment of atherosclerosis, it serves as an essential resource for researchers, healthcare professionals, and students alike. Although not an open-access journal, it is highly regarded within the academic community, highlighted by its Scopus rank of #54 out of 387 in its field, placing it in the 86th percentile. The journal's commitment to advancing knowledge in cardiovascular health underscores its integral role in guiding clinical practices and influencing future research directions.

VASCULAR PHARMACOLOGY

Pioneering research for a healthier vascular future.
Publisher: ELSEVIER SCIENCE INCISSN: 1537-1891Frequency: 12 issues/year

Vascular Pharmacology, published by Elsevier Science Inc, is a leading journal in the fields of pharmacology and molecular medicine, dedicated to advancing our understanding of vascular biology and therapeutic interventions. With an impressive impact factor reflecting its significant contribution to the scientific community, this journal seeks to publish ground-breaking research that elucidates the molecular mechanisms underlying vascular function and disease, as well as the pharmacological impact of new therapeutic agents. The journal operates under a dual access model, allowing for both subscription and open access options, ensuring that vital research is accessible to a wide audience. As of 2023, it holds a prestigious position in the Q1 category for pharmacology and ranks well in molecular medicine and physiology, reflecting its high quality and relevance. Whether you are a researcher, clinician, or student, Vascular Pharmacology serves as an essential resource to stay at the forefront of cardiovascular pharmacotherapy and vascular biology.

CLINICAL HEMORHEOLOGY AND MICROCIRCULATION

Enhancing Understanding, Inspiring Clinical Applications
Publisher: IOS PRESSISSN: 1386-0291Frequency: 8 issues/year

Clinical Hemorheology and Microcirculation, published by IOS Press, is a distinguished journal dedicated to advancing the scientific understanding of blood flow mechanics and microcirculatory phenomena. Since its inception in 1991, the journal has been pivotal in bridging the fields of cardiology, hematology, and physiology, as evidenced by its placement in the Q3 quartile across several categories in 2023. Positioned in the vibrant academic landscape of the Netherlands, Clinical Hemorheology and Microcirculation offers valuable insights to researchers and practitioners alike, enriching their knowledge and fostering innovation in clinical practices. With an ISSN of 1386-0291 and an E-ISSN of 1875-8622, the journal serves as a vital platform for disseminating high-quality research and reviews that explore the intricate dynamics of blood viscosity and microvascular function, essential to both health and disease. As readers delve into the journal, they will access rigorous studies that not only enhance theoretical understanding but also pave the way for potential clinical applications, making it a crucial resource for those invested in the future of cardiovascular and hematological research.

Nature Cardiovascular Research

Transforming research into impactful cardiovascular solutions.
Publisher: SPRINGERNATUREISSN: Frequency: 12 issues/year

Nature Cardiovascular Research, published by SpringerNature in Germany, stands as a premier journal dedicated to advancing the field of cardiovascular sciences. With an impressive 2023 categorization in the Q1 quartile across multiple disciplines—including Biochemistry, Genetics and Molecular Biology, Cardiology, and Medicine—this journal uniquely positions itself as a leading resource for pioneering research and innovative findings. Although currently not open access, it provides a rich repository of peer-reviewed articles that contribute directly to the evolving landscape of cardiovascular medicine. The journal aims to bridge the knowledge gap between basic science and clinical application, catering to researchers, healthcare professionals, and students alike who are immersed in the complexities of cardiovascular health. With robust Scopus rankings in key categories, Nature Cardiovascular Research is poised to shape future directions in the field, helping to foster a deeper understanding of cardiovascular diseases and their underlying mechanisms. Explore the latest research and be part of the conversation in one of the most impactful scientific domains.

JOURNAL OF CARDIOVASCULAR SURGERY

Advancing the frontiers of cardiovascular surgery.
Publisher: EDIZIONI MINERVA MEDICAISSN: 0021-9509Frequency: 6 issues/year

JOURNAL OF CARDIOVASCULAR SURGERY, published by EDIZIONI MINERVA MEDICA, stands as a pivotal resource in the field of cardiovascular medicine and surgical practices. With a rich history dating back to 1960 and ongoing contributions scheduled until 2024, this esteemed journal provides a platform for the dissemination of innovative research in cardiology and surgical techniques. Registered under ISSN 0021-9509 and E-ISSN 1827-191X, it holds a commendable standing reflected in its Scopus rankings, placing it in the second quartile for both cardiology and cardiovascular medicine, as well as surgery. Despite not currently offering Open Access, the journal remains a vital source for practitioners and researchers alike, facilitating a deeper understanding of advancing methodologies and clinical practices in cardiovascular surgery. The journal is headquartered in Turin, Italy, and is committed to nurturing academic excellence within the community, making it an essential read for professionals, researchers, and students striving to enhance their knowledge and expertise in this critical field.

Current Opinion in Physiology

Uncovering Innovative Perspectives in Physiology
Publisher: ELSEVIERISSN: Frequency: 6 issues/year

Current Opinion in Physiology, published by Elsevier, is a leading journal dedicated to the dynamic field of physiology. With an E-ISSN of 2468-8673, this journal provides a platform for the latest insights and perspectives, reflecting the evolving landscape of physiological research. Operating from the United Kingdom, the journal holds a respectable impact factor and is ranked Q2 in both general physiology and medical physiology categories, highlighting its prominence among the global academic community. With Scopus rankings placing it in the 64th and 60th percentiles within its respective categories, Current Opinion in Physiology serves as an essential resource for researchers, professionals, and students eager to stay informed about innovative theories and emerging trends in physiology. The publication emphasizes high-quality reviews that summarize current knowledge and future directions, ensuring readers gain valuable insights applicable in both clinical and research settings.

Vascular Health and Risk Management

Empowering research to transform vascular health practices.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1176-6344Frequency: 1 issue/year

Vascular Health and Risk Management is a leading peer-reviewed journal published by DOVE MEDICAL PRESS LTD, focusing on the critical areas of cardiology, endocrinology, and public health. With an impact factor that reflects its significance within the scientific community, this Open Access journal, established in 2005, has been committed to enhancing knowledge on the interplay between vascular health and various risk factors affecting patient outcomes. The journal is proudly based in New Zealand and is indexed across multiple categories, maintaining a prominent Q2 ranking in cardiology, endocrinology, diabetes, and several other medical disciplines as of 2023. By providing a platform for innovative research and comprehensive reviews, Vascular Health and Risk Management seeks to foster collaboration among healthcare professionals, enhance clinical practices, and ultimately improve patient care through rigorous scientific inquiry and disseminated knowledge. Researchers, professionals, and students will find invaluable insights that inform their work and advance the understanding of vascular-related health issues.

CIRCULATION

Unveiling Breakthroughs in Cardiovascular Science.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0009-7322Frequency: 50 issues/year

CIRCULATION is a premier journal in the field of cardiology and cardiovascular medicine, published by Lippincott Williams & Wilkins. With a distinguished history dating back to 1950, the journal has consistently been at the forefront of critical research, showcasing significant advancements and discoveries in cardiovascular health. It holds a remarkable Q1 ranking in both the fields of Cardiology and Physiology (medical) according to the 2023 category quartiles, demonstrating its influential role among the top publications in these disciplines. With an impressive Scopus ranking, placed 3rd out of 387 in Cardiology and 2nd out of 113 in Physiology, CIRCULATION is essential reading for researchers, practitioners, and students passionate about advancing their understanding of heart health and related medical sciences. Although the journal is not open access, it continues to foster scholarly exchange and innovation in cardiovascular research, making it an indispensable resource for quality insights and groundbreaking studies.

VASCULAR MEDICINE

Advancing cardiovascular health through impactful research.
Publisher: SAGE PUBLICATIONS LTDISSN: 1358-863XFrequency: 6 issues/year

Vascular Medicine is a premier academic journal for researchers and practitioners in the field of cardiovascular health, published by SAGE Publications Ltd. With an ISSN of 1358-863X and E-ISSN 1477-0377, this esteemed journal has been at the forefront of publishing quality research since its inception in 1992, with convergence extending to 2024. Ranked in the Q2 category for both Cardiology and Cardiovascular Medicine as well as for miscellaneous Medicine in 2023, it is recognized for its significant contributions to advancing knowledge and clinical practice within these domains. Its Scopus ranking situates it at #91 out of 387 in the field, reflecting its high impact and the relevance of its published research, which is crucial for addressing the challenges in vascular health today. Although it is not an open-access journal, Vascular Medicine remains dedicated to disseminating vital findings that bridge the gap between research and clinical application, making it an essential resource for medical researchers, healthcare professionals, and students alike.